Details for Patent: 7,814,943
Which drugs does patent 7,814,943 protect, and when does it expire?
Patent 7,814,943 protects VARITHENA and is included in one NDA.
This patent has twenty-three patent family members in eighteen countries.
Summary for Patent: 7,814,943
| Title: | Apparatus and method for dispensing foam |
| Abstract: | Apparatus for dispensing foam for the treatment of, inter alia, varicose veins. The apparatus includes a source of foam and a dispensing device which has an inlet in communication with the source of foam, a usable foam outlet, and a waste bleed outlet. The waste bleed outlet communicates with the inlet and with the useable foam outlet, and has a higher resistance to flow of foam than that of the usable foam outlet. The useable foam outlet may be blocked off such that foam may flow through the high resistance waste bleed outlet, and the usable foam outlet may be opened such that foam may flow through the usable foam outlet. |
| Inventor(s): | Anthony David Harman, David Dakin Iowerth Wright, Jam Willem Marinus Mijers, Stuart Brian William Kay, Christopher John Hurlstone, Julian Richard Dixon, Andrew Gordon Pocock, Brendan Hogan |
| Assignee: | Boston Scientific Medical Device Ltd |
| Application Number: | US10/571,608 |
|
Patent Claim Types: see list of patent claims | Use; Device; |
Drugs Protected by US Patent 7,814,943
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boston Scitfc | VARITHENA | polidocanol | SOLUTION;INTRAVENOUS | 205098-001 | Nov 25, 2013 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | A METHOD OF GENERATING AN INJECTABLE FOAM OF CONTROLLED DENSITY AND BUBBLE SIZE | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 7,814,943
| Foriegn Application Priority Data | ||
| Foreign Country | Foreign Patent Number | Foreign Patent Date |
| United Kingdom | 0321210.7 | Sep 10, 2003 |
| PCT Information | |||
| PCT Filed | September 09, 2004 | PCT Application Number: | PCT/GB2004/003864 |
| PCT Publication Date: | March 17, 2005 | PCT Publication Number: | WO2005/023678 |
International Family Members for US Patent 7,814,943
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 486023 | ⤷ Start Trial | |||
| Australia | 2004270475 | ⤷ Start Trial | |||
| Brazil | PI0414281 | ⤷ Start Trial | |||
| Canada | 2538172 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
